Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09GHB
|
|||
Former ID |
DIB011180
|
|||
Drug Name |
RO-4987655
|
|||
Synonyms |
CH-4987655; RO-04927350; MEK inhibitors (solid tumor), Roche
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 1 | [1] | |
Company |
F Hoffmann-La Roche Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H19F3IN3O5
|
|||
Canonical SMILES |
C1CC(=O)N(OC1)CC2=CC(=C(C(=C2F)F)NC3=C(C=C(C=C3)I)F)C(=O)NOCCO
|
|||
InChI |
1S/C20H19F3IN3O5/c21-14-9-12(24)3-4-15(14)25-19-13(20(30)26-31-7-5-28)8-11(17(22)18(19)23)10-27-16(29)2-1-6-32-27/h3-4,8-9,25,28H,1-2,5-7,10H2,(H,26,30)
|
|||
InChIKey |
FIMYFEGKMOCQKT-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 874101-00-5
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028214) | |||
REF 2 | MEK and the inhibitors: from bench to bedside. J Hematol Oncol. 2013; 6: 27. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.